Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
09/2003
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176495 HIV Integrase inhibitors
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
09/18/2003US20030176446 2,2-disubstituted 1,3-dioxolanes as antitussive agents
09/18/2003US20030176440 For protecting skeletal muscles against damage resulting from trauma, protecting skeletal muscles subsequent to muscle or systemic diseases, therapy of shock conditions, preserving donor tissue and organs used in transplants
09/18/2003US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
09/18/2003US20030175943 Biosynthesis of antitumor agents
09/18/2003US20030172470 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades.
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/17/2003EP1344109A2 Onium salts and the use therof as latent acids
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003EP1021426B1 Catalytic asymmetric epoxidation
09/17/2003EP0970066B1 Preparation of aminoepoxides from aminoaldehydes and an in situ formed halomethyl organometallic reagent
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1442415A Preparation method of iso propylidene shikimic acid and its new use
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620950 Starting from various bicyclo(5.3.1)undec-10-ene compounds of given formula having protected hydroxyl groups; use as antitumor agents
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2002053518A3 HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
09/11/2003US20030171585 Anti-inflammatory compounds
09/11/2003US20030171570 Acetal phosphoramidites for linking with a nucleotide sequence, converting the acetal group to aldehyde, for conjugating biomolecules; acetalization, oxidation
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1341746A1 Liquid crystalline compounds
09/10/2003EP1341742A1 Method for producing compounds having a cf2o bridge
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003CN1441805A Antitumoral analogue of Et-743
09/10/2003CN1441797A Chiral compounds Ôàó"
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/09/2003US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003016298A3 Process for making a compound containing cyclic and linear carbonate groups
09/04/2003US20030166963 Using tertiary amine catalyst
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030165532 Extracts from the fungus Guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus Gignardia sp. and its use in pharmaceutical compositions
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/03/2003EP1340981A2 Antibodies for detecting amphetamine derivatives
09/03/2003EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003CN1440414A Synthesis of cuttlefish compound
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
09/02/2003US6613803 Treating, preventing or ameliorating pain
08/2003
08/28/2003WO2003070714A1 Fluorous acetylation
08/28/2003WO2003070692A1 Novel propionic acid derivative
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162282 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents
08/28/2003US20030162281 Intermediates and improved processes for the preparation of neplanocin A
08/28/2003CA2477205A1 Novel propionic acid derivative
08/27/2003EP0926147B1 Process for preparing 1,3-dioxolane-4-methanol compounds
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0846111B1 Syntheses of optically pure compounds useful as garft inhibitors and their intermediates
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1119342C Process for preparing bromo-ortho-piperonaldehyde
08/27/2003CN1119341C Method for the continuous production of 1,3-dioxolan-2-ones
08/27/2003CN1119338C Alpha-(1-piperazinyl) ocetamido arenecarboxylic aicd derivatives as antidiabetic agents
08/27/2003CN1119310C Cyclo pentane-1,3-dione derivatives
08/26/2003US6610892 Process for preparing 2,7-dimethyl-2,4,6-octatrienal monoacetals
08/26/2003US6610482 Sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2002032844A8 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
08/21/2003US20030158427 Using Wittig or Wittig-Horner reaction; use in selective synthesis of various C40 carotenoids
08/21/2003US20030158259 Drugs for treating obesity and diabetes and animal feed additives
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003US20030157697 Intermediates and improved processes for the preparation of neplanocin A
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335899A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003EP0776330B1 Photolabile compounds and methods for their use
08/20/2003CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds
08/20/2003CN1118448C Process for producing benzyl-ethers
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608061 Bisaryl compound and medicament for cancer treatment comprising the same
08/19/2003CA2043733C Aromatic compounds
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066581A1 Urea linker derivatives for use as ppar modulators
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents
08/14/2003US20030153706 5- or 6-membered ring acetal structure is connected to a norbornene structure through a linker represented by -(CH2)m-m=1 to 8 used as monomer; polymer is sensitive to high energy radiation excellent resolution, and etching resistance
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153579 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153544 Fatty acid derivatives
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 183